Asia Pacific Polymerase Chain Reaction Technologies Market Size to register a growth of 7.3% CAGR

20-11-2018 | Report Format: Electronic (PDF)

Growth, Trends and Report Highlights

According to a new report Asia Pacific Polymerase Chain Reaction Technologies Market, published by KBV research, the Asia Pacific Polymerase Chain Reaction Technologies Market would witness market growth of 7.3% CAGR during the forecast period (2018 – 2024).

The Japan market would dominate the Asia Pacific Polymerase Chain Reaction Technologies Instruments Market by Country by 2024, growing at a CAGR of 6.2 % during the forecast period. The China market is expected to witness a CAGR of 6.3% during (2018 - 2024). Additionally, The India market is expected to witness a CAGR of 8.3% during (2018 - 2024).

The Biotech & Pharma Companies market dominated the Asia Pacific Polymerase Chain Reaction Technologies Market by End User in 2017. The Diagnostic Centers & Hospitals market is expected to witness a CAGR of 7.9% during (2018 - 2024).

The Reagents & Consumables market dominated the India Polymerase Chain Reaction Technologies Market by Product in 2017, and would achieve a market value of $202.1 million by 2024. The Services market is expected to witness a CAGR of 10.3% during (2018 - 2024).

Full Report:https://www.kbvresearch.com/asia-pacific-polymerase-chain-reaction-technologies-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Agilent Technologies, BioMérieux, Bio-Rad Laboratories, Inc., Hoffmann-La Roche Ltd., Fluidigm Corporation, LGC Limited, Qiagen NV, SYGNIS Pharma AG, Takara Bio, Inc., and Thermo Fisher Scientific.